Phase II Trial of Erlotinib for Japanese Patients With Previously Treated Non-small-cell Lung Cancer Harboring EGFR Mutations: Results of Lung Oncology Group in …
K Yamada, K Takayama, S Kawakami… - Japanese journal of …, 2013 - academic.oup.com
Objective Erlotinib has been reported to be useful for treatment of non-small-cell lung cancer
harboring mutation of the epidermal growth factor receptor gene EGFR-mt. However, no …
harboring mutation of the epidermal growth factor receptor gene EGFR-mt. However, no …
Sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in males, smokers, and non-adenocarcinoma lung cancer in patients with EGFR mutations
Z Zeng, H Chen, H Yan, J Yang… - … Journal of Biological …, 2013 - journals.sagepub.com
Introduction The demographical/clinical characteristics of being Asian, having an
adenocarcinoma, being female, and being a “never-smoker” are regarded as favorable …
adenocarcinoma, being female, and being a “never-smoker” are regarded as favorable …
呼吸器外科医の必要とする遠隔転移診断─ その目的とする所
森毅 - 日本放射線技術学会雑誌, 2013 - jstage.jst.go.jp
現在, 日本における死亡原因の第 1 位は 「がん」 であり, 2011 年の人口動態統計によると 1 年間に
357,305 人が 「がん」 で死亡している. その内の 70,297 人 (男性 50,782 人, 女性 19,511 人) …
357,305 人が 「がん」 で死亡している. その内の 70,297 人 (男性 50,782 人, 女性 19,511 人) …